These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


796 related items for PubMed ID: 3517452

  • 1. Monoclonal antibody against human ovarian tumor-associated antigens.
    Poels LG, Peters D, van Megen Y, Vooijs GP, Verheyen RN, Willemen A, van Niekerk CC, Jap PH, Mungyer G, Kenemans P.
    J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
    [Abstract] [Full Text] [Related]

  • 2. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
    Sakakibara K, Ueda R, Ohta M, Nakashima N, Tomoda Y, Takahashi T.
    Cancer Res; 1988 Aug 15; 48(16):4639-45. PubMed ID: 2456145
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies against ovarian carcinoma-associated antigens, raised by immunization with cyst fluids.
    Boerman O, Makkink K, Massuger L, Thomas C, Kenemans P, Hanselaar T, Poels L.
    Anticancer Res; 1989 Aug 15; 9(3):551-8. PubMed ID: 2764501
    [Abstract] [Full Text] [Related]

  • 4. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
    Mattes MJ, Look K, Furukawa K, Pierce VK, Old LJ, Lewis JL, Lloyd KO.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6741-50. PubMed ID: 3677104
    [Abstract] [Full Text] [Related]

  • 5. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
    Tsuji Y, Suzuki T, Nishiura H, Takemura T, Isojima S.
    Cancer Res; 1985 May 15; 45(5):2358-62. PubMed ID: 2580620
    [Abstract] [Full Text] [Related]

  • 6. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue.
    Mandeville R, Giroux L, Lecomte J, Chausseau JP, Dumas F, Ajdukovic I, Vidal D, Boury F.
    Cancer Detect Prev; 1987 May 15; 10(1-2):89-100. PubMed ID: 2436777
    [Abstract] [Full Text] [Related]

  • 7. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
    Cuijpers VM, Boerman OC, Salet van de Pol MR, Vooijs GP, Poels LG, Ramaekers FC.
    Acta Cytol; 1993 May 15; 37(3):272-9. PubMed ID: 8498129
    [Abstract] [Full Text] [Related]

  • 8. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL, Hayes DF, Kufe DW.
    Cancer Res; 1986 Oct 15; 46(10):5189-94. PubMed ID: 3530435
    [Abstract] [Full Text] [Related]

  • 9. Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas.
    van Niekerk CC, Boerman OC, Ramaekers FC, Poels LG.
    Am J Pathol; 1991 Feb 15; 138(2):455-63. PubMed ID: 1992770
    [Abstract] [Full Text] [Related]

  • 10. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW, Lee J, Stone MJ.
    Cancer Res; 1984 Nov 15; 44(11):4987-92. PubMed ID: 6207911
    [Abstract] [Full Text] [Related]

  • 11. Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodies.
    Boerman O, Massuger L, Makkink K, Thomas C, Kenemans P, Poels L.
    Anticancer Res; 1990 Nov 15; 10(5A):1289-95. PubMed ID: 2241105
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the specificity by immunohistology of a monoclonal antibody to a novel epithelial antigen of ovarian carcinomas.
    Mariani-Costantini R, Agresti R, Colnaghi MI, Ménard S, Andreola S, Rilke F.
    Pathol Res Pract; 1985 Aug 15; 180(2):169-80. PubMed ID: 3903701
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
    Bhattacharya M, Chatterjee SK, Barlow JJ, Fuji H.
    Cancer Res; 1982 May 15; 42(5):1650-4. PubMed ID: 6175395
    [Abstract] [Full Text] [Related]

  • 14. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
    Pancino G, Charpin C, Calvo F, Guillemin MC, Roseto A.
    Cancer Res; 1987 Aug 15; 47(16):4444-52. PubMed ID: 3607774
    [Abstract] [Full Text] [Related]

  • 15. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A, Gorstein F, Ohuchi N, Szpak CA, Johnston WW, Schlom J.
    J Natl Cancer Inst; 1986 Jun 15; 76(6):995-1006. PubMed ID: 3520078
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibody against human gallbladder carcinoma-associated antigen.
    Koyama S, Mukai R, Fukao K, Arimura H, Iwasaki Y, Osuga T.
    Cancer Res; 1987 Sep 01; 47(17):4667-73. PubMed ID: 3304618
    [Abstract] [Full Text] [Related]

  • 17. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
    Szpak CA, Johnston WW, Lottich SC, Kufe D, Thor A, Schlom J.
    Acta Cytol; 1984 Sep 01; 28(4):356-67. PubMed ID: 6205527
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
    Kimmel KA, Carey TE, Judd WJ, McClatchey KD.
    J Natl Cancer Inst; 1986 Jan 01; 76(1):9-19. PubMed ID: 2416979
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
    Brenner BG, Jothy S, Shuster J, Fuks A.
    Cancer Res; 1982 Aug 01; 42(8):3187-92. PubMed ID: 7046919
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal antibodies that discriminate between human ovarian carcinomas and benign ovarian tumours.
    Boerman OC, Makkink WK, Thomas CM, Hanselaar AG, Yedema CA, Kenemans P, Poels LG.
    Eur J Cancer; 1990 Feb 01; 26(2):117-27. PubMed ID: 2138906
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.